Searchable abstracts of presentations at key conferences in endocrinology

ea0063s12.3 | Craniopharyngioma; a challenging tumour to treat and a difficult aftermath | ECE2019

How to manage the long-term consequences of hypothalamic damages

Erfurth Eva Marie

When a craniopharyngioma (CP) causes hypothalamus (HT) damage this will result in hypothalamic obesity (HO), cognitive dysfunction and increased stroke mortality. Suggested treatment when the HT is affected by a CP is subtotal resection and in some cases followed by cranial radiotherapy (CRT). In the preoperative phase, a multidisciplinary team may suggest HT sparing surgery with subtotal tumour removal. If in spite of all efforts the HT is damaged, there will be an immediate ...

ea0037s20.2 | Endocrine consequences of childhood cancer treatment | ECE2015

Hypopituitarism in cancer survivors

Erfurth Eva Marie

Survival rates of childhood cancer have improved markedly and today more than 80% of those diagnosed with a pediatric malignancy will become 5-year survivors. Nevertheless, survivors exposed to cranial radiotherapy (CRT) are at particularly high risk for long-term morbidity, such as endocrine insufficiencies, metabolic complications and cardiovascular morbidity. Deficiencies of one or more anterior pituitary hormones have been described following therapeutic CRT for primary br...

ea0035n2 | (1) | ECE2014

Radiation-induced multiple late complications after childhood acute lymphoblastic leukemia: A case report

Follin Cecilia , Erfurth Eva Marie

Introduction: Acute lymphoblastic leukaemia (ALL) is the most common childhood malignancy and accounts for 25% of all childhood cancer. With dramatically improved survival rates the long term treatment complications are very important. ALL patients treated with cranial radiotherapy (CRT) and chemotherapy are at increased risk of GH deficiency (GHD), hyperparathyroidism, thyroid cancer and meningiomas.Method: We present a 45-year-old woman diagnosed with ...

ea0020s21.2 | Current problems in the management of pituitary tumours | ECE2009

Factors associated with hypothalamic morbidity in patients with craniopharyngiomas

Holmer Helene , Erfurth Eva Marie

Background: Adult craniopharyngioma (CP) patients without GH therapy exhibit high risk for cardiovascular disease (CVD) and mortality with a higher risk in women than in men. Approximately 50% of children treated for CP are obese at follow-up and hypothalamic damage seems to be a major cause. In GHD CP children GH treatment improves linear growth but does not ameliorate weight gain, but the impact of long-term GH therapy into adulthood is presently unknown.<p class="abstex...

ea0016p399 | Neuroendocrinology | ECE2008

Four years of growth hormone (GH) therapy improves markers of cardiovascular risk in GH deficient (GHD) survivors of childhood acute lymphoblastic leukaemia (ALL)

Follin Cecilia , Erfurth Eva Marie

Survivors of childhood (CO) ALL treated with prophylactic cranial radiotherapy (CRT) often exhibit (GHD) and increased cardiovascular risk. The aim of this study was to evaluate the effect of 4 years of GH therapy on cardiovascular risk factors in 16 former ALL patients and to compare them with matched population controls after 4 years.Sixteen former CO ALL patients (women=8), aged 24–37 years, treated with CRT (18–24 Gy) and chemotherapy with ...

ea0041ep878 | Pituitary - Clinical | ECE2016

Perioperative plasma cortisol levels during transsphenoidal operation of pituitary adenoma in ACTH sufficiency and deficiency

Borg Henrik , Fjalldal Sigridur , Siesjo Peter , Kahlon Babar , Erfurth Eva Marie

Introduction: The demand of cortisol rises during stress and to avoid acute cortisol deficiency, patients undergoing transsphenoidal surgery at Skåne University Hospital (Sweden) receive peri- and postoperative substitution with hydrocortisone (HC), even at normal ACTH function. Some anesthetics are known to affect cortisol levels.This study aimed to assess the perioperative cortisol plasma levels during transsphenoidal surgery in ACTH sufficient an...

ea0037ep661 | Pituitary: basic and neuroendocrinology | ECE2015

Long-term follow-up of cranially irradiated childhood leukaemia survivors show cognitive impairment and progressive decline in sustained attention, in spite of on complete hormone replacement

Follin Cecilia , Johansson Aki , Osterberg Kai , Rovira Andrea , Jansson Magdalena , Wiebe Thomas , Erfurth Eva Marie

Background: Survivors of childhood leukaemia (ALL) treated with cranial radiotherapy (CRT) are at risk for cognitive impairment. Whether the impairment progresses with follow-up time and if survivors with cognitive impairment have an increased risk for overweight, is unknown. We aimed to investigate the long-term cognitive functioning in ALL survivors treated with CRT in comparison to matched controls.Method: Cognitive functioning was investigated in 38 ...

ea0022p637 | Neuroendocrinology and Pituitary (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Rapid bone loss 23 years after diagnosis for childhood acute lymfoblastic leukaemia (ALL) in spite of GH therapy

Follin Cecilia , Link Katarina , Wiebe Thomas , Moell Christian , Bjork Jonas , Erfurth Eva Marie

Context: Acute lymphoblastic leukaemia (ALL) is the most common pediatric malignancy and its treatment includes many known risk factors for low bone mineral density (BMD), e.g. glucocorticosteroids, methotrexat and cranial radiotherapy (CRT).Objective: To evaluate bone mineral density (BMD) and markers of bone turn over in a group of adults with childhood onset ALL, treated with CRT and to evaluate the effect of 5 years with, and 8 years without GH thera...

ea0016p369 | Growth factors | ECE2008

New occurrence of diabetes mellitus in patients with adult onset GH deficiency (GHD) on GH therapy is dependent on the presence of metabolic syndrome at baseline: data from the Hypopituitary Control and Complication Study (HypoCCS)

Attanasio Andrea , Mo Daojun , Chanson Philippe , Ho Ken , Woodmansee Whitney , Kleinberg David , Erfurth Eva Marie

Patients with adult onset GHD (AO-GHD) manifest features of the metabolic syndrome (MetS) (abdominal obesity, dyslipidemia and insulin resistance), a condition associated with increased risk of diabetes mellitus (DM).We assessed metabolic status before and after 2 years of GH treatment and the occurrence of de novo DM in 712 patients with AO-GHD from HypoCCS drawn from the US (32.2%) and Europe (67.8%). Patients were divided into four BMI categori...

ea0041ep741 | Neuroendocrinology | ECE2016

Hypothalamic dysfunction revealed by magnetic resonance diffusion tensor imaging in childhood leukemia survivors treated with cranial radiotherapy but not in craniopharyngioma survivors

Follin Cecilia , Fjalldal Sigridur , Svard Daniel , van Westen Danielle , Gabery Sanaz , Petersen AEsa , Latt Jimmy , Rylander Lars , Erfurth Eva Marie

Background: Metabolic complications with obesity are frequent in childhood acute lymphoblastic leukemia (ALL) survivors treated with cranial radiotherapy (CRT). Childhood onset Craniopharyngioma (CP) survivors without hypothalamic (HT) involvement are spared gross obesity. Magnetic resonance diffusion tensor imaging (DTI) provides information of microstructure function of the brain and quantified as fractional anisotrophy (FA), mean diffusivity (MD), axial and radial diffusivi...